These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 9305508

  • 1. Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Reisberg B, Schneider L, Doody R, Anand R, Feldman H, Haraguchi H, Kumar R, Lucca U, Mangone CA, Mohr E, Morris JC, Rogers S, Sawada T.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():8-18. PubMed ID: 9305508
    [Abstract] [Full Text] [Related]

  • 2. Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Gauthier S, Bodick N, Erzigkeit E, Feldman H, Geldmacher DS, Huff J, Mohs R, Orgogozo JM, Rogers S.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():6-7. PubMed ID: 9305507
    [No Abstract] [Full Text] [Related]

  • 3. Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Feldman H, Anand R, Blesa R, Dubois B, Gray J, Homma A, Mohr E, Morris JC, Parys W, Raschig A, Robillard A.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():61-4. PubMed ID: 9305520
    [No Abstract] [Full Text] [Related]

  • 4. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Ferris SH, Lucca U, Mohs R, Dubois B, Wesnes K, Erzigkeit H, Geldmacher D, Bodick N.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():34-8. PubMed ID: 9305514
    [No Abstract] [Full Text] [Related]

  • 5. Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Antuono P, Doody R, Gilman S, Huff J, Scheltens P, Ueda K, Khachaturian ZS.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():22-5. PubMed ID: 9305510
    [Abstract] [Full Text] [Related]

  • 6. Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines.
    Harvey RJ, Sciulli CG, Mason RM, Whitehouse PJ.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():29-32. PubMed ID: 9305512
    [No Abstract] [Full Text] [Related]

  • 7. Clinical trials of treatment for noncognitive symptoms of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Homma A, Brodaty H, Bruno G, Cummings JL, Gilman S, Gracon S, McKeith IG.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():54-5. PubMed ID: 9305518
    [No Abstract] [Full Text] [Related]

  • 8. Cultural issues in the clinical diagnosis of Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Amaducci L, Baldereschi M, Doody R, Chandra V, Gaines AD.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():19-21. PubMed ID: 9305509
    [No Abstract] [Full Text] [Related]

  • 9. Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Post SG, Beerman B, Brodaty H, Gaines AW, Gauthier SG, Geldmacher DS, Hill S, Homma A, Rossor MN, Whitehouse PJ, Winblad B.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():26-8. PubMed ID: 9305511
    [No Abstract] [Full Text] [Related]

  • 10. Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Whitehouse PJ, Orgogozo JM, Becker RE, Gauthier S, Pontecorvo M, Erzigkeit H, Rogers S, Mohs RC, Bodick N, Bruno G, Dal-Bianco P.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():56-60. PubMed ID: 9305519
    [No Abstract] [Full Text] [Related]

  • 11. length of clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Levy R.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():33. PubMed ID: 9305513
    [No Abstract] [Full Text] [Related]

  • 12. Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.
    Bodick N, Forette F, Hadler D, Harvey RJ, Leber P, McKeith IG, Riekkinen PJ, Rossor MN, Scheltens P, Shimohama S, Spiegel R, Tanaka S, Thal LJ, Urata Y, Whitehouse P, Wilcock G.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():50-3. PubMed ID: 9305517
    [Abstract] [Full Text] [Related]

  • 13. Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Winblad B, Hill S, Beermann B, Post SG, Wimo A.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():39-45. PubMed ID: 9305515
    [No Abstract] [Full Text] [Related]

  • 14. Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Thal LJ, Carta A, Doody R, Leber P, Mohs R, Schneider L, Shimohama S, Silber C.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():46-9. PubMed ID: 9305516
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Global measures: utility in defining and measuring treatment response in dementia.
    Reisberg B.
    Int Psychogeriatr; 2007 Jun; 19(3):421-56. PubMed ID: 17480241
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.
    Cullum CM, Saine K, Chan LD, Martin-Cook K, Gray KF, Weiner MF.
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jun; 14(2):103-8. PubMed ID: 11417663
    [Abstract] [Full Text] [Related]

  • 19. Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study.
    Rockwood K, Black S, Bedard MA, Tran T, Lussier I, TOPS Study Investigators.
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):312-9. PubMed ID: 17006874
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.